dequalinium has been researched along with tubocurarine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haylett, DG; Shah, M | 1 |
| Ahring, PK; Christophersen, P; Jørgensen, TD; Olesen, SP; Strøbaek, D | 1 |
| Carignani, C; Chen, MX; Pula, G; Roncarati, R; Terstappen, GC | 1 |
3 other study(ies) available for dequalinium and tubocurarine
| Article | Year |
|---|---|
The pharmacology of hSK1 Ca2+-activated K+ channels expressed in mammalian cell lines.
Topics: Animals; Apamin; Calcium; Cell Line; Chlorocebus aethiops; COS Cells; Dequalinium; Humans; Kidney; Nicotinic Antagonists; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Rats; Small-Conductance Calcium-Activated Potassium Channels; Transfection; Tubocurarine; Xenopus | 2000 |
Pharmacological characterization of small-conductance Ca(2+)-activated K(+) channels stably expressed in HEK 293 cells.
Topics: Amino Acid Sequence; Apamin; Bicuculline; Cell Line; Cloning, Molecular; Electrophysiology; GABA Antagonists; Humans; Kinetics; Molecular Sequence Data; Neuromuscular Nondepolarizing Agents; Patch-Clamp Techniques; Plasmids; Potassium Channels; Potassium Channels, Calcium-Activated; Small-Conductance Calcium-Activated Potassium Channels; Toxins, Biological; Tubocurarine | 2000 |
Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Apamin; CHO Cells; Cricetinae; Humans; Phenothiazines; Potassium Channels; Potassium Channels, Calcium-Activated; Small-Conductance Calcium-Activated Potassium Channels | 2001 |